EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Error-corrected ultradeep next-generation sequencing for detection of clonal haematopoiesis and haematological neoplasms – sensitivity, specificity and accuracy

Melinda L Tursky iD, Crisbel M Artuz, Melissa Rapadas, Gary A Wittert, Timothy J Molloy, David D Ma

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0318300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Melinda L Tursky und 5 weiteren Autor:innen. Beteiligte Einrichtung: Blood, Stem Cell, and Cancer Research Programme, St Vincent's Centre for Applied Medical Research and Department of Haematology, St Vincent's Hospita…. Hauptthemen laut MEDLINE: Hematologic Neoplasms, High-Throughput Nucleotide Sequencing, Clonal Hematopoiesis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Arrow Bone Marrow Transplant Foundation, St Vincent's Hospital Sydney Haematology Department, St. Vincent's Clinic Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clonal haematopoiesis of indeterminate potential (CHIP) is an aging-associated phenomenon that has recently been correlated with a broad spectrum of human diseases, including haematological malignancy, cytopenia, coronary heart disease, stroke, and overall mortality. CHIP is defined as a somatic variant in blood cells with an allele frequency (VAF) ≥ 0.02, however recent reports show smaller clones are associated with poorer clinical outcome. Error-corrected ultradeep next-generation sequencing (NGS) assays detecting variants < 0.02 VAF also have clinical value for monitoring measurable residual disease (MRD) for myeloid neoplasms. However, limited data are available on optimal parameters, limits of detection, and accuracy of ultra-sensitive detection. We investigated parameters to improve accuracy of Illumina sequencing-by-synthesis method, including read depth, input DNA quantity, and molecular barcoding-based data filtering, while adhering to clinical accreditation criteria. Validation data were generated from reference standards and reference samples from a clinically accredited pathology laboratory. Analytical range measurements included linearity and bias, and precision included repeatability, reproducibility and detection rate. The lower limit of detection was ≥ 0.004 (0.4%) at depth > 3,000 × . Trueness measured using reference standards demonstrated a sensitivity, specificity, positive and negative predictive values, and accuracy of 100%, including FLT3-ITD, and 100% concordance was achieved with reference samples for reported variants and absence of variants. Sequencing blood samples from 383 community-dwelling adults (mean depth 3758×) revealed 2,190 somatic variants/sample, > 99.9% were < 0.02 VAF. Our data including cost-benefit analysis enables pathology and research laboratories to make informed decisions for detection of CHIP (VAF ≥ 0.02), sub-CHIP (VAF 0.01–0.02) and MRD (VAF ≥ 0.004).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsHigh-Throughput Nucleotide SequencingClonal HematopoiesisHumansSensitivity and SpecificityReproducibility of ResultsGene FrequencyNeoplasm, Residual

Autor:innen und Institutionen

  • Blood, Stem Cell, and Cancer Research Programme, St Vincent's Centre for Applied Medical Research and Department of Haematology, St Vincent's Hospital, Sydney, Australia.
  • School of Clinical Medicine, St Vincent's Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, Kensington, Australia.
  • Freemasons Centre for Male Health and Well-Being, South Australian Health and Medical Research Institute and Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.

ORCID-Profile: Melinda L Tursky

Förderung

  • Arrow Bone Marrow Transplant Foundation
  • St Vincent's Hospital Sydney Haematology Department
  • St. Vincent's Clinic Foundation

Zitieren

APA

Tursky, M. L., Artuz, C. M., Rapadas, M., Wittert, G. A., Molloy, T. J., & Ma, D. D. (2025). Error-corrected ultradeep next-generation sequencing for detection of clonal haematopoiesis and haematological neoplasms – sensitivity, specificity and accuracy. PLOS ONE. https://doi.org/10.1371/journal.pone.0318300

Vancouver

Tursky ML, Artuz CM, Rapadas M, Wittert GA, Molloy TJ, Ma DD. Error-corrected ultradeep next-generation sequencing for detection of clonal haematopoiesis and haematological neoplasms – sensitivity, specificity and accuracy. PLOS ONE. 2025. doi:10.1371/journal.pone.0318300

BibTeX
@article{Tursky2025,
  author = {Tursky, Melinda L and Artuz, Crisbel M and Rapadas, Melissa and Wittert, Gary A and Molloy, Timothy J and Ma, David D},
  title = {Error-corrected ultradeep next-generation sequencing for detection of clonal haematopoiesis and haematological neoplasms – sensitivity, specificity and accuracy},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0318300}
}
Kostenlos starten →